SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 35 filers reported holding SINOVAC BIOTECH LTD in Q3 2017. The put-call ratio across all filers is - and the average weighting 2.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $86,000 | -17.3% | 10,000 | -24.2% | 0.01% | -25.0% |
| Q4 2017 | $104,000 | +11.8% | 13,200 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $93,000 | +57.6% | 13,200 | +50.0% | 0.01% | +33.3% |
| Q2 2017 | $59,000 | +110.7% | 8,800 | +76.0% | 0.01% | +50.0% |
| Q2 2014 | $28,000 | -78.0% | 5,000 | -71.8% | 0.00% | -76.5% |
| Q1 2014 | $127,000 | – | 17,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,718,735 | $340,000,000 | 7.22% |
| Vivo Capital, LLC | 5,900,000 | $38,173,000 | 4.18% |
| Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 0.82% |
| Financial Gravity Asset Management, Inc. | 988 | $3,197,686 | 0.04% |
| Yorktown Management & Research Co Inc | 149,786 | $4,494 | 0.01% |
| Renaissance Technologies | 2,375,841 | $1,537 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,661 | $10,747 | 0.00% |
| NORTHERN TRUST CORP | 13,787 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 412 | $2,666 | 0.00% |